Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Biofinderon Jun 30, 2018 5:40pm
342 Views
Post# 28256319

Next 18 months is busy time: Everything is coming up daisies

Next 18 months is busy time: Everything is coming up daisiesH2 2018 PBI-4050 partnership(s)  $$$
H2 2018 IPF phase 3 trial
H2 2018 Alstrom phase 3 trial
 
H1 2019 FDA Ryplazim marketing approval  $$$
H1 2019 FDA awards pediatric voucher  $$$
H1 2019 regional Ryplazim partnerships  $$$
H1 2019 Tympanic Repair data readout
H1 2019 IVIG Canada marketing approval  $$$
H2 2019 IVIG FDA marketing approval  $$$
H2 2019 PBI-4050 U.K. marketing approval to Alstrom patients  $$$

Sent from my iPad
Bullboard Posts